© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Ciprofloxacin Hydrochloride regularly stands out as a key ingredient in the fight against bacterial infections. This substance acts as the hydrochloride salt form of ciprofloxacin, a synthetic broad-spectrum fluoroquinolone antibiotic. The molecular formula shows up as C17H18FN3O3·HCl, and it achieves a molecular weight of roughly 385.8. In the material world, people find it most often as a white to slightly off-white crystalline powder or as small, flat flakes. Moisture or light does not impact its core structure right away, and the material maintains a pretty stable integrity under standard storage conditions.
This solid compound adopts a crystal structure, secured together with both covalent and ionic bonds. Chemists see a fusion of aromatic rings and fluorine atoms nestled within its core, boosting its efficacy and lending it strength in the field of medicinal chemistry. The hydrochloride piece provides additional solubility in water, letting the substance dissolve well for prepared solutions. Skilled technicians have determined the melting point to land between 300 and 310°C, which hints at both durability and stability at common laboratory and industrial temperatures. The density falls near 1.7 g/cm³, making it manageable for mixing with other pharmaceutical substances and easy enough to measure without specialized equipment.
People working in pharmaceutical manufacturing expect precise specifications for ciprofloxacin hydrochloride. This product usually arrives in tightly sealed containers, as either powder, crystalline solid, or thin flakes. Some suppliers offer pearls or a granular form for easier dosing. In testing, this chemical jumps out as nearly odorless and demonstrates a faint, bitter taste that matches many synthetic drugs in its category. Its solubility in water at room temperature reaches up to 10 mg/mL, which means it dissolves well enough for both intravenous and oral applications. Storage at room temperature in a moisture-free space keeps the product viable, avoiding caking or clumping, and ensures consistent reaction during pharmaceutical processing.
Trading ciprofloxacin hydrochloride on the global market calls for clear product identification using a Harmonized System (HS) Code. Most shipments declare 29419090, which covers a broad range of organic compounds and pharmaceutical raw materials. This code streamlines customs procedures and helps ensure the safe flow of materials between countries, while also helping authorities maintain safety standards and track distribution patterns.
The molecule presents a unique profile through the union of fluorine, piperazinyl, and quinoline groups. These chemical groups contribute not only to its pharmacological actions but also to its physical properties, including high thermal stability and resistance to photodegradation. Handling the product in its powder or flake state requires reliable weighing devices and antistatic surfaces to prevent loss or airborne contamination. Each batch comes with detailed certificates listing pH (typically between 3 and 5 when dissolved in water), relative density, loss on drying, and purity percentage. Laboratories depend on batch-to-batch consistency to maintain trust in the antibiotic and prevent variable outcomes during drug manufacturing.
Pharmaceutical companies rely on ciprofloxacin hydrochloride as a raw material due to its strong antibacterial activity and reliable record against a range of pathogens. It often forms the crucial component in hospital-grade tablets, capsules, and solutions. From a supply chain perspective, raw material traceability gains importance each year. Reliable production practices cut the risk of contamination, and regulatory agencies audit sources for both safety and quality standards. Because ciprofloxacin hydrochloride is classified as both safe for medicinal use and hazardous as a chemical substance, handling rules follow strict protocols. Prolonged or unnecessary exposure can cause irritation to skin, eyes, or the respiratory tract. Ingestion of pure material outside controlled dosing may result in adverse effects, so training remains critical for all handlers. Proper personal protective equipment, including gloves, safety glasses, and dust masks, reduces direct exposure risk. Spills should be addressed quickly using non-sparking tools, and waste must go in clearly labeled chemical disposal units.
Contact with high concentrations of ciprofloxacin hydrochloride in its raw form can harm the human body, especially if inhaled or absorbed through the skin. Past safety data sheets and published incident reports confirm that unguarded handling leads to respiratory irritation, headaches, or even allergic responses in sensitive individuals. The chemical’s powdery state presents the largest risk, since dust spreads easily through air movement. Pharmacies and facilities using this substance enforce comprehensive ventilation and containment systems to stop cross-contamination. Regular safety drills, hands-on chemical safety training, and well-written material safety data sheets promote a culture of responsibility. By treating ciprofloxacin hydrochloride as a useful but potentially hazardous material, production teams keep one foot firmly in the realm of safety, protecting workers and ensuring the final pharmaceutical products meet required purity and potency standards.
